With sales and margins increased sharply in 2016, DCL recorded a profit after tax of 90 billion, up to 50% compared with 2015.

With sales and margins increased sharply in 2016, DCL recorded a profit after tax of 90 billion, up to 50% compared with 2015.

Mr. Nguyen Toan Thang, Deputy General Director in charge of business said separately in December, DCL achieved sales of more than 90 billion, which is the highest month, up t0 50% compared with the average of the previous month.

Previouse highest revenues ever achieved in May 3/2016 of 75 billion / month.

DCL conference gratitude to customers in 2016

Thanks to strong revenue growth in the last months, especially in December, both in 2016, the sales revenue of the Company reached approximately 763 billion. Compared with 2015, this figure increased by 13%, but according to Mr. Thang, these are positive results by all branches of local surplus increased growth surged.

Specifically, in the three segments of the company, capsule sales has not been increased because of full operating capacity in last period, Vikimco medical equipment segment increased 60%, pharmaceuticals increased by 20% over the previous year.

Business results of DCL in recent years

Mr Thang said, it is estimated that by 2016, DCL after-tax profit of over 90 billion, an increase of approximately 50% compared with the net profit in 2015, as net gains mainly from trading activities.

According to Mr Thang, since FIT becoming a major shareholder of DCL, the application of strict management model from FIT helped DCL better control cash flow, definitively settle the debt status bad. In addition, the Company changed its distribution policy and focus on sales, DCL compound growth achieved by increasing the average profit margin and sales.

2016, Company achieved net profitability ratio on revenues of approximately 11.8%, compared to 9% in 2015.